TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - COVID-19
KW - Humans
KW - Opioid-Related Disorders/drug therapy
KW - Pandemics
KW - SARS-CoV-2
KW - United States
KW - opioid treatment programs
KW - opioid use disorder
KW - Social distancing
KW - telehealth
AU - J. Cantor
AU - A. Laurito
A1 - 
AD - RAND Corporation, Santa Monica, CA, 1776 Main Street, m5159, Santa Monica, CA 90401, USA. Electronic address: jcantor@rand.org.; Department of Public Administration, University of Illinois at Chicago, 412 S. Peoria St., 136, Chicago, IL 60607 (MC 278), USA. Electronic address: malaurit@uic.edu.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
DO - 10.1016/j.jsat.2021.108393
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PY - 2021
SN - 1873-6483; 0740-5472; 0740-5472
SP - 108393
T1 - The new services that opioid treatment programs have adopted in response to COVID-19
T2 - Journal of substance abuse treatment
TI - The new services that opioid treatment programs have adopted in response to COVID-19
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U2 - 34118694
U3 - 10.1016/j.jsat.2021.108393
VL - 130
VO - 1873-6483; 0740-5472; 0740-5472
Y1 - 2021
Y2 - Nov
ER -